APA (7th ed.) Citation

BG, F., WJ, S., JP, B., F, C., LR, S., CO, E., . . . SB, H. (2005). A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease. Alimentary pharmacology & therapeutics, 21(4), 373. https://doi.org/10.1111/j.1365-2036.2005.02336.x

Chicago Style (17th ed.) Citation

BG, Feagan, et al. "A Randomized, Double-blind, Placebo-controlled Trial of CDP571, a Humanized Monoclonal Antibody to Tumour Necrosis Factor-alpha, in Patients with Corticosteroid-dependent Crohn's Disease." Alimentary Pharmacology & Therapeutics 21, no. 4 (2005): 373. https://doi.org/10.1111/j.1365-2036.2005.02336.x.

MLA (9th ed.) Citation

BG, Feagan, et al. "A Randomized, Double-blind, Placebo-controlled Trial of CDP571, a Humanized Monoclonal Antibody to Tumour Necrosis Factor-alpha, in Patients with Corticosteroid-dependent Crohn's Disease." Alimentary Pharmacology & Therapeutics, vol. 21, no. 4, 2005, p. 373, https://doi.org/10.1111/j.1365-2036.2005.02336.x.